Survival of a mixed culture of microencapsulated probiotic strains against the gastrointestinal barrier in vitro

IF 0.2 4区 农林科学 Q4 VETERINARY SCIENCES
Luz Alba Caballero–Pérez, Rene Tejedor–Arias, Elaysa Josefina Salas–Osorio
{"title":"Survival of a mixed culture of microencapsulated probiotic strains against the gastrointestinal barrier in vitro","authors":"Luz Alba Caballero–Pérez, Rene Tejedor–Arias, Elaysa Josefina Salas–Osorio","doi":"10.52973/rcfcv-e33296","DOIUrl":null,"url":null,"abstract":"Encapsulating materials preserve the viability of probiotics under gastrointestinal conditions. The aim of the research was to evaluate the protective effect of an encapsulating matrix, composed for the first time with three prebiotic materials to maintain the viability of a mixed culture of spray–dried microencapsulated probiotics under simulated gastrointestinal and prebiotic conditions. Microcapsules of four formulations with better viability were then evaluated by inoculating microencapsulated and free strains in MRS broth, adjusting three pH values, bile salts, broth with and without carbohydrate (prebiotic test), incubated at 36 ± 1°C / 24 h; then the percentage of post–treatment cell survival was calculated. Showing that, formulation 1 presented higher barrier protection with average counts: 7.31 log CFU·g-1 lactobacilli and 7.75 log CFU·g-1 (Saccharomyces boulardii) / 4 h (SGF), reaching 6.78 log CFU·g-1 in the four formulations (SIF) with a higher average survival rate 79.79% and 85.06% SGF and SIF, in vitro. On the other hand, the prebiotic test maintained average counts of 9.40 log CFU·g-1 (Lactobacillus spp.) and 6.99 log CFU·g-1 (S. boulardii) / 24 h. The protection exerted by the microspheres under simulated gastrointestinal and prebiotic conditions at therapeutic levels (≥ 106 CFU·mL-1) was demonstrated.","PeriodicalId":54478,"journal":{"name":"Revista Cientifica-Facultad De Ciencias Veterinarias","volume":"16 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Cientifica-Facultad De Ciencias Veterinarias","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52973/rcfcv-e33296","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Encapsulating materials preserve the viability of probiotics under gastrointestinal conditions. The aim of the research was to evaluate the protective effect of an encapsulating matrix, composed for the first time with three prebiotic materials to maintain the viability of a mixed culture of spray–dried microencapsulated probiotics under simulated gastrointestinal and prebiotic conditions. Microcapsules of four formulations with better viability were then evaluated by inoculating microencapsulated and free strains in MRS broth, adjusting three pH values, bile salts, broth with and without carbohydrate (prebiotic test), incubated at 36 ± 1°C / 24 h; then the percentage of post–treatment cell survival was calculated. Showing that, formulation 1 presented higher barrier protection with average counts: 7.31 log CFU·g-1 lactobacilli and 7.75 log CFU·g-1 (Saccharomyces boulardii) / 4 h (SGF), reaching 6.78 log CFU·g-1 in the four formulations (SIF) with a higher average survival rate 79.79% and 85.06% SGF and SIF, in vitro. On the other hand, the prebiotic test maintained average counts of 9.40 log CFU·g-1 (Lactobacillus spp.) and 6.99 log CFU·g-1 (S. boulardii) / 24 h. The protection exerted by the microspheres under simulated gastrointestinal and prebiotic conditions at therapeutic levels (≥ 106 CFU·mL-1) was demonstrated.
微囊化益生菌菌株混合培养对胃肠道屏障的体外存活
包封材料可以在胃肠道条件下保持益生菌的活力。本研究的目的是评估首次由三种益生元材料组成的包封基质在模拟胃肠道和益生元条件下维持喷雾干燥微胶囊益生菌混合培养活力的保护作用。将微囊化菌和游离菌分别接种于MRS培养液中,调整3种pH值、胆汁盐、加糖和不加糖的培养液(益生元试验),在36±1℃/ 24 h下培养,以评价4种活性较好的配方微胶囊;然后计算处理后细胞存活率。结果表明,配方1具有较高的屏障保护作用,平均乳酸菌数量分别为7.31 log CFU·g-1和7.75 log CFU·g-1(博氏酵母菌)/ 4 h (SGF), 4种配方(SIF)的体外平均存活率分别为79.79%和85.06%,达到6.78 log CFU·g-1。另一方面,益生元试验维持了9.40 log CFU·g-1(乳酸杆菌)和6.99 log CFU·g-1(博氏沙门氏菌)/ 24 h的平均计数。在模拟胃肠道和益生元条件下(≥106 CFU·mL-1),微球的保护作用得到了证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
66
审稿时长
18-36 weeks
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信